EAS: Estonian healthtech startup raises 2.3M for polygenic risk score-based genetic tests to estimate the risk of common cancers

Tartu-based startup Antegenes has raised 2.3 million euros in funding from Enterprise Estonia and the European Institute of Innovation and Technology. Antegenes develops and implements advanced genetic tests based on polygenic risk scores technology for precision prevention of major complex diseases. The startup will use the funding to enter new foreign markets and accordingly enlarge [...]